AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ADENOSINE TRIPHOSPHATE
5 registrations across 3 African markets— 5 active
Markets with ADENOSINE TRIPHOSPHATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ATEPADENE 30MG GELU BTE(1TUB X 30) LABORATOIRE XO gélule 30mg (30) | 🇲🇬Madagascar | LABORATOIRE X.O. | active | — |
| ATEPADENE comprime / 30mg | 🇸🇳Senegal | X.O LABORATOIRE | active | — |
| ATEPADENE comprime / 30mg | 🇸🇳Senegal | X.O LABORATOIRE | active | — |
| ATEPADENE 30MG GELU BTE(1TUB X 30) LABORATOIRE XO gélule 30mg (30) | 🇲🇬Madagascar | LABORATOIRE X.O. | active | — |
| ATEPADENE GELULE | 🇲🇦Morocco | — | active | — |
ADENOSINE TRIPHOSPHATE in Africa — Regulatory Overview
ADENOSINE TRIPHOSPHATE is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Senegal, Morocco. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 5 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.